Ciitizen

company

About

Ciitizen's mission is empower patients with complete control of their health data.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$17M
Industries
Health Care
Founded date
Sep 11, 2017
Number Of Employee
11 - 50
Operating Status
Active

Ciitizen’s mission is to provide Earth’s 7.3 billion citizens with control of their complete health information and give them the choice of sharing it with whomever they want. Period. With this new ownership, patients can share their health history with caregivers, share for second opinions, and with companies/researchers who may hold the answer to their treatment.

All patients have a right to all of their health information, yet existing portals pull only minimal clinical information from a fraction of health care institutions. Current “interoperability” initiatives leave the patient out of the picture and often rely on armies of manual labor to extract key health insights from unstructured textual data—an expensive model which doesn’t scale.

In the near future, citizens will walk into a clinical facility and, with a simple tap of a mobile device, release their health information to themselves, where Ciitizen normalizes unstructured data from across the healthcare ecosystem into actionable visualizations for patients, their caregivers, and clinicians.

Ciitizen has assembled an all-star team, led by its CEO, Anil Sethi (last company was sold to Apple) and is backed by a strong investment team led by Andreessen Horowitz, Verily, Section 32 and others.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$17M
Ciitizen has raised a total of $17M in funding over 2 rounds. Their latest funding was raised on Jan 16, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 16, 2019 Series A $17M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ciitizen is funded by 1 investors. Verily are the most recent investors.
Investor Name Lead Investor Funding Round
Verily Series A